Is Tellgen Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Tellgen Corp (300642.SZ) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Tellgen Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Tellgen Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Tellgen Corp?

Muslim investors may consider investing in Tellgen Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Tellgen Corp classified as NOT COVERED?

Musaffa determines the Shariah status of Tellgen Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Tellgen Corp updated?

The Shariah compliance status of Tellgen Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Tellgen Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Tellgen Corp?

You can check the latest Shariah compliance status of Tellgen Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Tellgen Corp 300642.SZ

Last Updated: May 15, 12:00 AM·SZSE

Tellgen Corp. Stock Analysis 300642.SZ

China Health Care Small Cap

Tellgen Corp. engages in the developing, manufacturing and marketing of molecular diagnostic products. The company is headquartered in Shanghai, Shanghai and currently employs 683 full-time employees. The company went IPO on 2017-04-21. The firm's products mainly cover the fields of immunity, molecules and biochemistry, involving autoimmunity, tumors, cardiovascular, infection, hormones, metabolism and other fields. The firm's main products include tumor marker detection products, human papillomavirus (HPV) nucleic acid detection products, autoimmune disease detection products, methylation mutation detection products and other products. The firm conducts its business in the domestic and overseas markets.

Shariah Compliance Report

An extensive business and financial screening of the company which specifies why a stock is halal or haram!

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.

I accept the above